Analysis of the Utilization of Antiemetics in Cancer Patients of 87 Hospitals from 2012 to 2014
10.6039/j.issn.1001-0408.2017.11.09
- VernacularTitle:全国87家医院2012-2014年肿瘤患者止吐药使用情况分析
- Author:
Ping LIN
;
Wei ZHANG
;
Jiancun ZHEN
- Keywords:
Cancer;
Antiemetics;
Analysis of drug utilization;
Rational use
- From:
China Pharmacy
2017;28(11):1470-1474
- CountryChina
- Language:Chinese
-
Abstract:
OBJECTIVE:To provide reference for rational use of antiemetics in cancer patients. METHODS:The utilization of antiemetics in cancer outpatients and inpatients from 87 hospitals involved inHospital Prescription Analysisproject during 2012-2014 was analyzed statistically by time or by hospital category. RESULTS:14 antiemetics were used in 87 hospitals during 2012-2014. The consumption sum and person number of antiemetics in cancer outpatients were 5763000 yuan and 34000 persons [22000 yuan/(year·hospital),133.1 person/(year·hospital) in average];those of cancer inpatients were 61711000 yuan and 515000 persons [256000 yuan/(year·hospital),2137.9 person/(year·hospital) in average];those of outpatient were lower than those of inpatient. The ratio of consumption sum of antiemetics in cancer outpatients and inpatients were 5.2‰-34.0‰;the ratio of person number ranged 2.9%-10.9%. Those of inpatient were higher than those of outpatient;those of special hospital were higher than those of comprehensive hospital. Main drugs included ondansetron,tropisetron,metoclopramide and palonosetron. CONCLU-SIONS:Antiemetics are frequently used in cancer patients,especially for 5-HT3 receptor antagonists and metoclopramide.
